title: [Endoscopic management of luminal stenosis in inflammatory bowel disease].
abstract: Luminal stenosis is frequent in Crohn's disease (CD) due to transmural involvement. Before any endoscopic treatment, the presence of neoplastic stenosis should always be excluded. Endoscopic balloon dilatation has been used in several series to treat benign stenosis, mainly in CD with involvement of the distal ileon, colon or surgical anastomosis, with success rates of 51% to 85%, although recurrence is high. The concomitant use of injected steroids (triamcinolone) after endoscopic dilatation produces longer-lasting results, but there are few published reports. In patients with luminal stenosis refractory to conventional endoscopy, three emerging techniques may be useful: self-expanding metallic stents, biodegradable endoprostheses and intralesional infliximab injection.
authors.affiliation: Unidad de Endoscopias, Servicio de Aparato Digestivo, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. vlorenzo.germanstrias@gencat.cat
authors.forename: Vicente
authors.initials: V
authors.lastname: Lorenzo-Zúñiga
authors.forename: Esther
authors.initials: E
authors.lastname: García-Planella
authors.forename: Vicente
authors.initials: V
authors.lastname: Moreno De Vega
authors.forename: Eugeni
authors.initials: E
authors.lastname: Domènech
authors.forename: Jaume
authors.initials: J
authors.lastname: Boix
mesh_terms: D020341:Absorbable Implants; D000714:Anastomosis, Surgical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use; D002404:Catheterization; D003131:Combined Modality Therapy; D003251:Constriction, Pathologic; D016099:Endoscopy, Gastrointestinal / Q000379:methods*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D000069285:Infliximab; D015552:Injections, Intralesional; D007415:Intestinal Obstruction / Q000601:surgery / Q000628:therapy*; D015607:Stents; D014221:Triamcinolone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014221:Triamcinolone; D000069285:Infliximab